Form 4: Elanco Executive Acquires Deferred Stock Units

Rajeev A. Modi, Elanco's EVP, acquired 60.2735 deferred stock units on January 9, 2026, increasing his direct beneficial ownership.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. (ELAN), acquired 60.2735 deferred stock units (DSUs).
• The transaction occurred on January 9, 2026.
• Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
• The DSUs were acquired at a price of $23.47 per unit.
• Following this acquisition, Modi directly beneficially owns 7,480.3494 derivative securities (DSUs).
• These DSUs will settle in cash or shares of common stock upon termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. An executive acquiring more company equity (even deferred) can be seen as a positive signal of confidence, but it's a small, routine transaction that doesn't significantly alter the company's outlook.

Positives

• An executive acquiring additional company equity, even in the form of deferred units, can signal confidence in the company's future performance and long-term strategy.

Future Outlook

The deferred stock units are structured to settle in cash or shares of common stock following termination of employment or during a specified future year, indicating a long-term incentive component of executive compensation.

Management Comments

• Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
• Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

This transaction reflects a routine executive compensation event, common across the animal health industry and broader corporate landscape, where equity-based incentives are used to align management interests with long-term shareholder value.

Comparison to Industry Standards

• Executive compensation plans involving deferred stock units are a common practice across various industries, including the animal health sector, to align executive interests with long-term shareholder value.
• Companies like Zoetis Inc. (ZTS) and IDEXX Laboratories, Inc. (IDXX) also utilize similar equity-based compensation structures for their executives, demonstrating this as a standard industry practice.

Stakeholder Impact

• Shareholders: The acquisition of DSUs by an executive aligns management's interests with shareholders, potentially fostering long-term value creation.
• Employees: Reflects standard executive compensation practices within the company, which can influence employee morale and retention.

Next Steps

• The deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units by an executive as part of their compensation plan. While it indicates continued alignment of executive interests with the company, the transaction size is small and does not provide new material information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Elanco Animal Health, ELAN, Rajeev A. Modi, Deferred Stock Units, DSU, Insider Transaction, Executive Compensation, Stock Acquisition